Polysaccharides derived from Yamoa™ (Funtumia elastica) prime γδ T cells in vitro and enhance innate immune responses in vivo

Jill C. Graff, Emily M. Kimmel, Brett Freedman, Igor A. Schepetkin, Jeff Holderness, Mark T. Quinn, Mark A. Jutila, Jodi F. Hedges

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Yamoa™ (ground bark of Funtumia elastica tree) is marketed and sold as a dietary supplement with anecdotal therapeutic effects in the treatment of asthma and hay fever. We determined that Yamoa™ and Yamoa™-derived polysaccharides affected innate immunity, in part, by priming γδ T cells. Gene expression patterns in purified bovine γδ T cells and monocytes induced by Yamoa™ were similar to those induced by ultrapure lipopolysaccharide (uLPS). In the presence of accessory cells, Yamoa™ had priming effects that were similar to those of LPS on bovine and murine γδ T cells, but much more potent than LPS on human γδ T cells. The bioactive component of Yamoa™ was delineated to a complex polysaccharide fraction (Yam-I). Intraperitoneal injection of Yamoa™ and Yam-I in mice induced rapid increases in peritoneal neutrophils directed by changes in chemokine expression. In support of a unique agonist found in Yam-I, similar peritonitis responses were also observed in TLR4- and MyD88-deficient mice. Therapeutic treatment with Yam-I resulted in decreased bacterial counts in feces from mice with Salmonella enterica serotype typhimurium (ST)-induced enterocolitis. This characterization of the immune stimulatory properties of polysaccharides derived from Yamoa™ suggests mechanisms for the anecdotal positive effects of its ingestion and that these polysaccharides show potential for application in innate protection from disease.

Original languageEnglish
Pages (from-to)1313-1322
Number of pages10
JournalInternational Immunopharmacology
Volume9
Issue number11
DOIs
Publication statusPublished - Oct 2009
Externally publishedYes

Fingerprint

Rubber
Innate Immunity
Polysaccharides
Dioscorea
T-Lymphocytes
Enterocolitis
Salmonella enterica
Seasonal Allergic Rhinitis
In Vitro Techniques
yamoa
Bacterial Load
Therapeutic Uses
Dietary Supplements
Intraperitoneal Injections
Peritonitis
Chemokines
Feces
Lipopolysaccharides
Monocytes
Neutrophils

Keywords

  • γδ T cells
  • Dietary supplement
  • Lipopolysaccharide
  • Peritonitis
  • Priming
  • Yamoa™

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Pharmacology

Cite this

Polysaccharides derived from Yamoa™ (Funtumia elastica) prime γδ T cells in vitro and enhance innate immune responses in vivo. / Graff, Jill C.; Kimmel, Emily M.; Freedman, Brett; Schepetkin, Igor A.; Holderness, Jeff; Quinn, Mark T.; Jutila, Mark A.; Hedges, Jodi F.

In: International Immunopharmacology, Vol. 9, No. 11, 10.2009, p. 1313-1322.

Research output: Contribution to journalArticle

Graff, Jill C. ; Kimmel, Emily M. ; Freedman, Brett ; Schepetkin, Igor A. ; Holderness, Jeff ; Quinn, Mark T. ; Jutila, Mark A. ; Hedges, Jodi F. / Polysaccharides derived from Yamoa™ (Funtumia elastica) prime γδ T cells in vitro and enhance innate immune responses in vivo. In: International Immunopharmacology. 2009 ; Vol. 9, No. 11. pp. 1313-1322.
@article{a6db09d5bdb344499e73a507b2393cbf,
title = "Polysaccharides derived from Yamoa™ (Funtumia elastica) prime γδ T cells in vitro and enhance innate immune responses in vivo",
abstract = "Yamoa™ (ground bark of Funtumia elastica tree) is marketed and sold as a dietary supplement with anecdotal therapeutic effects in the treatment of asthma and hay fever. We determined that Yamoa™ and Yamoa™-derived polysaccharides affected innate immunity, in part, by priming γδ T cells. Gene expression patterns in purified bovine γδ T cells and monocytes induced by Yamoa™ were similar to those induced by ultrapure lipopolysaccharide (uLPS). In the presence of accessory cells, Yamoa™ had priming effects that were similar to those of LPS on bovine and murine γδ T cells, but much more potent than LPS on human γδ T cells. The bioactive component of Yamoa™ was delineated to a complex polysaccharide fraction (Yam-I). Intraperitoneal injection of Yamoa™ and Yam-I in mice induced rapid increases in peritoneal neutrophils directed by changes in chemokine expression. In support of a unique agonist found in Yam-I, similar peritonitis responses were also observed in TLR4- and MyD88-deficient mice. Therapeutic treatment with Yam-I resulted in decreased bacterial counts in feces from mice with Salmonella enterica serotype typhimurium (ST)-induced enterocolitis. This characterization of the immune stimulatory properties of polysaccharides derived from Yamoa™ suggests mechanisms for the anecdotal positive effects of its ingestion and that these polysaccharides show potential for application in innate protection from disease.",
keywords = "γδ T cells, Dietary supplement, Lipopolysaccharide, Peritonitis, Priming, Yamoa™",
author = "Graff, {Jill C.} and Kimmel, {Emily M.} and Brett Freedman and Schepetkin, {Igor A.} and Jeff Holderness and Quinn, {Mark T.} and Jutila, {Mark A.} and Hedges, {Jodi F.}",
year = "2009",
month = "10",
doi = "10.1016/j.intimp.2009.07.015",
language = "English",
volume = "9",
pages = "1313--1322",
journal = "International Immunopharmacology",
issn = "1567-5769",
publisher = "Elsevier",
number = "11",

}

TY - JOUR

T1 - Polysaccharides derived from Yamoa™ (Funtumia elastica) prime γδ T cells in vitro and enhance innate immune responses in vivo

AU - Graff, Jill C.

AU - Kimmel, Emily M.

AU - Freedman, Brett

AU - Schepetkin, Igor A.

AU - Holderness, Jeff

AU - Quinn, Mark T.

AU - Jutila, Mark A.

AU - Hedges, Jodi F.

PY - 2009/10

Y1 - 2009/10

N2 - Yamoa™ (ground bark of Funtumia elastica tree) is marketed and sold as a dietary supplement with anecdotal therapeutic effects in the treatment of asthma and hay fever. We determined that Yamoa™ and Yamoa™-derived polysaccharides affected innate immunity, in part, by priming γδ T cells. Gene expression patterns in purified bovine γδ T cells and monocytes induced by Yamoa™ were similar to those induced by ultrapure lipopolysaccharide (uLPS). In the presence of accessory cells, Yamoa™ had priming effects that were similar to those of LPS on bovine and murine γδ T cells, but much more potent than LPS on human γδ T cells. The bioactive component of Yamoa™ was delineated to a complex polysaccharide fraction (Yam-I). Intraperitoneal injection of Yamoa™ and Yam-I in mice induced rapid increases in peritoneal neutrophils directed by changes in chemokine expression. In support of a unique agonist found in Yam-I, similar peritonitis responses were also observed in TLR4- and MyD88-deficient mice. Therapeutic treatment with Yam-I resulted in decreased bacterial counts in feces from mice with Salmonella enterica serotype typhimurium (ST)-induced enterocolitis. This characterization of the immune stimulatory properties of polysaccharides derived from Yamoa™ suggests mechanisms for the anecdotal positive effects of its ingestion and that these polysaccharides show potential for application in innate protection from disease.

AB - Yamoa™ (ground bark of Funtumia elastica tree) is marketed and sold as a dietary supplement with anecdotal therapeutic effects in the treatment of asthma and hay fever. We determined that Yamoa™ and Yamoa™-derived polysaccharides affected innate immunity, in part, by priming γδ T cells. Gene expression patterns in purified bovine γδ T cells and monocytes induced by Yamoa™ were similar to those induced by ultrapure lipopolysaccharide (uLPS). In the presence of accessory cells, Yamoa™ had priming effects that were similar to those of LPS on bovine and murine γδ T cells, but much more potent than LPS on human γδ T cells. The bioactive component of Yamoa™ was delineated to a complex polysaccharide fraction (Yam-I). Intraperitoneal injection of Yamoa™ and Yam-I in mice induced rapid increases in peritoneal neutrophils directed by changes in chemokine expression. In support of a unique agonist found in Yam-I, similar peritonitis responses were also observed in TLR4- and MyD88-deficient mice. Therapeutic treatment with Yam-I resulted in decreased bacterial counts in feces from mice with Salmonella enterica serotype typhimurium (ST)-induced enterocolitis. This characterization of the immune stimulatory properties of polysaccharides derived from Yamoa™ suggests mechanisms for the anecdotal positive effects of its ingestion and that these polysaccharides show potential for application in innate protection from disease.

KW - γδ T cells

KW - Dietary supplement

KW - Lipopolysaccharide

KW - Peritonitis

KW - Priming

KW - Yamoa™

UR - http://www.scopus.com/inward/record.url?scp=70249104143&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70249104143&partnerID=8YFLogxK

U2 - 10.1016/j.intimp.2009.07.015

DO - 10.1016/j.intimp.2009.07.015

M3 - Article

C2 - 19671448

AN - SCOPUS:70249104143

VL - 9

SP - 1313

EP - 1322

JO - International Immunopharmacology

JF - International Immunopharmacology

SN - 1567-5769

IS - 11

ER -